UBS Group Initiates Coverage on Astera Labs (NASDAQ:ALAB)

Research analysts at UBS Group started coverage on shares of Astera Labs (NASDAQ:ALAB) in a note issued to investors on Tuesday, Marketbeat.com reports. The brokerage set a “neutral” rating and a $180.00 price target on the stock. UBS Group’s price objective indicates a potential downside of 7.25% from the stock’s current price.

Other analysts have also issued reports about the stock. Citigroup began coverage on shares of Astera Labs in a research report on Thursday, April 2nd. They issued a “buy” rating and a $200.00 price target on the stock. Weiss Ratings lowered shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 23rd. Loop Capital began coverage on shares of Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 target price on the stock. Royal Bank Of Canada reiterated an “outperform” rating and set a $250.00 target price on shares of Astera Labs in a research report on Tuesday. Finally, Barclays set a $165.00 target price on shares of Astera Labs in a research report on Thursday, January 15th. Fifteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $199.74.

Astera Labs Price Performance

NASDAQ ALAB opened at $194.06 on Tuesday. The firm has a market capitalization of $33.23 billion, a price-to-earnings ratio of 159.07, a P/E/G ratio of 3.78 and a beta of 1.78. The company’s fifty day moving average is $130.79 and its two-hundred day moving average is $153.77. Astera Labs has a 52-week low of $59.32 and a 52-week high of $262.90.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.07. The company had revenue of $270.58 million for the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The business’s quarterly revenue was up 91.8% on a year-over-year basis. During the same period last year, the business posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, sell-side analysts expect that Astera Labs will post 1.48 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Jitendra Mohan sold 325,693 shares of Astera Labs stock in a transaction dated Friday, April 17th. The shares were sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the completion of the transaction, the chief executive officer directly owned 4,079,322 shares of the company’s stock, valued at $702,214,489.08. This trade represents a 7.39% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 94,971 shares of Astera Labs stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the transaction, the chief operating officer directly owned 1,531,301 shares of the company’s stock, valued at $189,590,376.81. This represents a 5.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 1,064,888 shares of company stock worth $150,764,723 over the last ninety days. Corporate insiders own 12.50% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

A number of institutional investors have recently modified their holdings of ALAB. Royal Bank of Canada raised its stake in shares of Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after acquiring an additional 95,409 shares during the last quarter. AQR Capital Management LLC raised its stake in shares of Astera Labs by 213.4% in the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after acquiring an additional 7,756 shares during the last quarter. Empowered Funds LLC raised its stake in shares of Astera Labs by 917.3% in the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after acquiring an additional 4,183 shares during the last quarter. First Trust Advisors LP raised its stake in shares of Astera Labs by 102.0% in the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after acquiring an additional 56,952 shares during the last quarter. Finally, Brown Advisory Inc. raised its stake in shares of Astera Labs by 54.9% in the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock worth $505,000 after acquiring an additional 1,977 shares during the last quarter. 60.47% of the stock is owned by institutional investors.

Key Headlines Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Big cloud/hyperscaler deal tailwinds — analysts link Amazon/Anthropic’s $100B build‑out to follow‑on orders for connectivity silicon like Astera’s, underpinning multi‑year revenue upside. Read More.
• Positive Sentiment: Product demand and earnings momentum — coverage highlights surging Aries and Taurus demand and strong fundamentals (Q4 revenue +91.8%, EPS beat, Q1 guidance), supporting further upside as AI data‑center builds continue. Read More.
• Positive Sentiment: Analyst price‑target lift amplified buying — recent upgrades (including RBC’s $250 PT) triggered a sharp intraday rally and heavier volume as momentum traders piled in. Read More.
• Neutral Sentiment: UBS starts coverage at “neutral” with a $180 target — a formal coverage initiation that limits near‑term runway implied by some bulls (PT ~7% below the latest price). Read More.
• Neutral Sentiment: Momentum and hedge‑fund attention — technical buy signals and hedge‑fund interest can magnify moves (higher intraday volatility) but don’t change underlying fundamentals. Read More.
• Negative Sentiment: Significant insider selling — CEO and a director executed large Rule 10b5‑1 sales this month (including a multi‑million‑dollar block), which investors may view as supply pressure despite being planned trades. Read More.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.